Jefferies' Clients, Employees and Shareholders Contribute $9,250,000 to Over 85 Charities for Coronavirus Relief in Memory of Peg Broadbent
Jefferies announced today a total donation to over 85 different charities of $9.25 million as a result of a firmwide global effort to raise money to honor the memory of their late CFO Peg Broadbent, who was a victim of this terrible disease.
Through the firm’s Global Coronavirus Relief Charity Day held May 27th, Jefferies’ clients helped to generate $7.65 million in donated net trading commissions. In addition, Jefferies as a firm will donate $1 million directly, and voluntary donations from Jefferies’ 3,822 employees totaled $600,000.
“We could not be prouder of our entire Jefferies family for raising $9.25 million and are greatly appreciative of the incredible partnership our clients have shown us in supporting our fight against Covid-19. The full $9.25 million will be wired today and go to direct relief efforts at over 85 worthy global charities who are each in the front lines helping those most impacted by the Coronavirus global pandemic. We went broadly to a large number of charities globally as this is truly a tragedy that affects all of us and, in particular, those who are most disadvantaged and in the greatest need.
The charities selected are both big and small and represent everything from food banks, child care services, assistance with PPE and other medical supplies, support for front line medical workers, assistance for afflicted military personnel, local teen centers, support for police and fire, workforce training and re-training and many other worthy areas that are most in need. We thank our employees and clients for aiding in the selection of many of these remarkable charities.
Finally, all of us at Jefferies would like to thank all the dedicated professionals working tirelessly on the front line to help those in need. They are the true heroes whom we are honored to help in Peg’s name.”
Contributions in the following amounts will be immediately distributed to these respected organizations:
|
NYC Mayor’s Fund | Peg’s Cure |
|
$ 150,000 |
|
All Hands and Hearts |
|
$ 150,000 |
|
American Heart Association |
$ 150,000 |
|
|
Bowery Mission |
$ 150,000 |
|
|
Hackensack Meridian Health Foundation |
$ 150,000 |
|
|
Houston Police Foundation |
|
$ 150,000 |
|
International Rescue Committee |
|
$ 150,000 |
|
Robin Hood Foundation |
|
$ 150,000 |
|
Strive |
|
$ 150,000 |
|
The Bass Foundation |
|
$ 150,000 |
|
World Central Kitchen |
|
$ 150,000 |
|
We Can #TogetherFromHome |
|
$ 100,000 |
|
Achievement First |
|
$ 100,000 |
|
Aktion Deutschland Hilft |
|
$ 100,000 |
|
Alzheimer’s Association |
|
$ 100,000 |
|
Ambitious About Autism |
|
$ 100,000 |
|
Barnardo’s |
$ 100,000 |
|
|
BMS Family Health and Wellness Center |
|
$ 100,000 |
|
Bob Woodruff Foundation |
|
$ 100,000 |
|
Boys & Girls Clubs of the Austin Area |
|
$ 100,000 |
|
Brewers Community Foundation |
|
$ 100,000 |
|
Buttle UK |
|
$ 100,000 |
|
Central Texas Food Bank |
|
$ 100,000 |
|
Chelsea and Westminster Hospital NHS Foundation Trust |
|
$ 100,000 |
|
Chrysalis |
$ 100,000 |
|
|
City Harvest |
$ 100,000 |
|
|
Citymeals on Wheels |
|
$ 100,000 |
|
Columbia Children's Hospital |
|
$ 100,000 |
|
Community Food Bank of New Jersey |
|
$ 100,000 |
|
Covenant House |
|
$ 100,000 |
|
Doctors Without Borders |
|
$ 100,000 |
|
East High – EOP (Education Partnership Organization) |
|
$ 100,000 |
|
Elmhurst Hospital Charity |
|
$ 100,000 |
|
Family Promise of Bergen County |
|
$ 100,000 |
|
FarmLink |
|
$ 100,000 |
|
Feeding America |
|
$ 100,000 |
|
Food Bank For New York City |
|
$ 100,000 |
|
Foodlink |
|
$ 100,000 |
|
Habitat for Humanity Japan |
|
$ 100,000 |
|
Hance Family Foundation |
|
$ 100,000 |
|
Humanity & Inclusion |
|
$ 100,000 |
|
Hunger Free America |
|
$ 100,000 |
|
Imperial Health Charity |
|
$ 100,000 |
|
Kids in Crisis |
|
$ 100,000 |
|
Kohka Foundation |
|
$ 100,000 |
|
Lahey Clinic Foundation |
|
$ 100,000 |
|
Mail Force Charity |
|
$ 100,000 |
|
Martha’s Table |
|
$ 100,000 |
|
Médecins Sans Frontières |
|
$ 100,000 |
|
Memorial Hermann Foundation |
|
$ 100,000 |
|
My Sister's Place |
|
$ 100,000 |
|
National Emergencies Trust |
|
$ 100,000 |
|
Navajo Nation Covid-19 Relief Fund |
|
$ 100,000 |
|
Nazareth Housing |
|
$ 100,000 |
|
Neighbourly Community Fund |
|
$ 100,000 |
|
NHS Charities Together |
|
$ 100,000 |
|
Northwell Health's COVID-19 Emergency Fund |
|
$ 100,000 |
|
NYU Langone |
|
$ 100,000 |
|
Off Their Plate |
|
$ 100,000 |
|
Oxfam India |
|
$ 100,000 |
|
Philippine Disaster Resilience Foundation |
|
$ 100,000 |
|
Red Hook Initiative |
|
$ 100,000 |
|
Rosetree Trust |
|
$ 100,000 |
|
Royal College of Nursing Foundation |
|
$ 100,000 |
|
RVNAhealth |
|
$ 100,000 |
|
Second Harvest |
|
$ 100,000 |
|
Sempre Con Voi (Always with You) |
|
$ 100,000 |
|
St Michael’s House |
|
$ 100,000 |
|
TBD 1 |
|
$ 100,000 |
|
TBD 2 |
|
$ 100,000 |
|
TBD 3 |
|
$ 100,000 |
|
TCF Bank |
|
$ 100,000 |
|
The Care Workers Charity |
|
$ 100,000 |
|
The River Fund New York |
|
$ 100,000 |
|
The United Way of Central Indiana COVID-19 Relief Fund |
|
$ 100,000 |
|
The World Health Organization (WHO) |
|
$ 100,000 |
|
Trinity's Services & Food for the Homeless |
|
$ 100,000 |
|
The Trussell Trust |
|
$ 100,000 |
|
UNICEF |
|
$ 100,000 |
|
UR Medicine Home Care’s Meals on Wheels |
|
$ 100,000 |
|
URMC COVID-19 Emergency Fund |
|
$ 100,000 |
|
Valpo Surf Project, Inc. |
|
$ 100,000 |
|
Volunteers of Legal Service |
|
$ 100,000 |
|
Our Dream Their Smile |
|
$ 100,000 |
|
West Side Campaign Against Hunger |
|
$ 100,000 |
|
Women United in Philanthropy |
|
$ 100,000 |
|
Women's Center of Greater Danbury |
|
$ 100,000 |
|
|
|
|
Jefferies Group LLC is the largest independent, global, full-service investment banking firm headquartered in the U.S. Focused on serving clients for nearly 60 years, Jefferies is a leader in providing insight, expertise and execution to investors, companies and governments. Our firm provides a full range of investment banking, advisory, sales and trading, research and wealth management services across all products in the Americas, Europe and Asia. Jefferies Group LLC is a wholly owned subsidiary of Jefferies Financial Group Inc. (NYSE: JEF), a diversified financial services company.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200528005663/en/
Contact information
Richard Khaleel, +1 212 284 2556, rkhaleel@jefferies.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release
I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 10:00:00 EET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA ® Commercialization in Central and Eastern Europe7.1.2026 09:30:00 EET | Press release
Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13 markets across Central and Eastern Europe for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). Under the terms of the agreement, Daiichi Sankyo will be responsible for the manufacturing and supply of VANFLYTA while GENESIS Pharma will lead medical affairs, market access and commercialization efforts in Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. Financial terms of the agreement are not being disclosed. VANFLYTA was approved in the EU in November 2023 for the treatment of adult patients with newly diagnosed FLT3-ITD positive AML in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, and as maintenance monotherap
Thales Powers CES*-Winning Post-Quantum Chip From Samsung Electronics7.1.2026 09:15:00 EET | Press release
Quantum computers, with their unprecedented processing power, will ultimately challenge today’s encryption standards. This is why Thales welcomes the CES 2026 recognition awarded to the new post-quantum–ready security chip from Samsung Electronics' System LSI Business, which embeds Thales’ secure operating system and quantum-resistant cryptographic libraries. This breakthrough represents a major step forward in protecting connected devices against both current cyberattacks and tomorrow’s quantum-era threats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106145232/en/ Thales’ hardened OS enables Samsung's award-winning security chip to deliver hardware-based, quantum-resistant protection from the moment devices power on. Ultimately, it ensures that encrypted data and device credentials remain secure against both classical and quantum attacks, preserving confidentiality, integrity and long-term trust, even in a post-quantu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
